Piramal Pharma Ltd’s Post

Our 2023 Audited Results show that we have multiplied by 2.2 times EBITDA in the period 2020-23, reaching €18.5 MM and a net profit of €9.2 MM with a growth of 24% compared to 2022. #LLYCResults2023 In addition, our organic EBITDA growth represents 6%. More information here 🔗https://ow.ly/mXOv30sBeuY 🗣️"Our results reflect a solid and sustained evolution that position us to pursue the growth outlined in our 2023/2025 strategic plan and investment roadmap" - Alejandro Romero, Global CEO of LLYC.

Gimme Credit Investment Grade Top Ten Report highlighted in Barron's today! "A number of companies that took advantage of past years’ low interest rates “are now realizing merger synergies that are boosting earnings before interest, taxes, depreciation, and amortization (EBITDA)..." #Gimmecredit #FixedIncome #CorporateBonds #InvestmentGrade

Please find attached, the I&M Group Plc Earnings Note for its FY2023 earnings.   We recommend a BUY on I&M Group with a target price of KES 23.60, representing an upside potential of 7.0% from the current market price of KES 22.05 (March 27th, 2024). We expect the Group’s mix of digitization, product innovation, and diversification to consolidate and boost performance.   For more information, read through the attached Earnings Note.

📢 Exciting news from the 2024 AGM season! 📢 As we wrap up the 2024 AGM season, we're thrilled to share insights from a period marked by adaptability, resilience, and innovation. Across Denmark, Norway, and Italy, Euronext Securities coordinated and supported over 550 AGMs, embracing virtual and hybrid formats. 🌐💼 This season has highlighted new directions for shareholder engagement and corporate governance amidst evolving global dynamics and rising shareholder expectations. Our experts have identified key trends that are shaping the future of AGMs, with a focus on technology integration, transparency, and stakeholder participation. 💡🤝 Here are some highlights from the season: 🔹 AGMs held: 550+ (2023: 425+) 🔹 Highest online attendance at a hybrid AGM: 700+ (2023: 580+) 🔹 Highest attendance at a physical AGM: 4,900+ (2023: 1,600+) Read our full article, "Redefining Shareholder Engagement: Insights from the 2024 AGM Season," to learn more about these exciting developments! 👉 https://lnkd.in/drMHxSaQ #AGM2024 #ShareholderEngagement #CorporateGovernance #Innovation #VirtualAGM #HybridMeetings

CWG concludes FY 2023 with an impressive 66% revenue growth, marking a highlight at its 2023 Annual General Meeting. Despite prevailing economic challenges, CWG is delighted to report a major achievement, with total revenue surging to N23.5 billion for FY 2023. This increase of 66% compared to N14.2 billion in 2022 demonstrates the company's robust market standing and effective strategic implementation. This performance sets a solid foundation for the upcoming year, and we eagerly anticipate continued growth and success. #CWGAGM Adewale Adeyipo, Austin Okere, Afolabi S., Tinu Adeyemi ACIPM, HRPL, SHRM-CP, ANITAD, Abisola Oshin, Ireti Yusuf, Seun Koshoedo, Philip Obioha, Harriet Attram Yartey, Peter Mugizi Tumusiime

Omda’s quarterly report for the Q1-24 is available on our website. Omda continues to deliver profitable growth and Q1-24 saw revenues grow organically 5%, reaching NOK 106 million. Profitability also increased, with the EBITDA margin hitting 14%, up from 5% for the same period last year. Omda CEO Sverre Flatby is optimistic for the rest of the year: “While our Business Areas continue to improve margins, Omda is increasing its efforts on M&A opportunities. We have identified several attractive candidates, which are in various stages of development. Backed by our cash reserve, last-year’s bond refinancing, and expected cash from operations going forward, we are well positioned to act on the right opportunities.”      Get the full report and view the webcast here: https://lnkd.in/d7xPy5_V #omda #healthcare #innovation #quarterlyreport

Today, we shared our first-quarter earnings results. We delivered strong adjusted results in the quarter that were better than our expectations as we continue to drive strong operational execution, maintain strong spending discipline, and benefit from significant operating leverage. I want to thank our team for the work they have done in successfully executing across our three strategic priorities. Their disciplined work has created value and returned capital to shareholders with the successful spin out of our healthcare business, Solventum. They have also helped reduce risk by reaching two large settlements while making progress on the exit of PFAS manufacturing. Most importantly, our teams have made tremendous progress on fundamentally improving how we work, which is driving better performance across the business. We delivered a strong start to the year. As we look ahead, we are focused on building on our momentum, supporting expectations for a return to organic top-line growth, margin expansion, investments in high growth and attractive end markets and continued strong cash generation. This leaves us well-positioned for long-term success and consistent value creation for our customers and shareholders. 

Weekly Market For Week Ending 23 February 2024: In a nutshell, the week's market saw a 10.42% surge in total turnover to TZS 3.70 billion, driven by TBL, contributing 55.1% of the total turnover. Local investors dominated the market, accounting for 100% in buying and 61.26% in selling. Despite slight declines in total and domestic market capitalization (0.07% and 0.09% respectively), there were notable share price gains for DCB, TPCC, and DSE, while NMB and SWIS faced losses. The fixed income market showed a robust bond turnover of TZS 93.83 billion, encompassing both treasury and corporate bonds with a face value of TZS 80.28 billion

IMCO achieved significant milestones and investment successes in 2023, a year that challenged many investors with market volatility and heightened inflation. From delivering strong weighted average net returns to welcoming 4 new clients, here are some of the highlights from IMCO’s 2023 Annual Report. Learn more here: https://lnkd.in/gJqnZiS5

#XCMGnews Our 2023 Annual Financial Report is out and the results are truly exceptional. We're thrilled to share that our strategic focus on high-quality development and new energy sectors has dramatically accelerated our growth. On the global front, our efforts have borne fruit with a staggering 33.7% increase in operating income from international markets. This expansion underscores our growing influence and commitment to global excellence. #XCMG #SolidtoSucceed #annualreport